Branch Expands AI Measurement With ChatGPT Ads Attribution Across App, Web and Desktop
24-09-2026 16:03 via prnewswire.com

Branch Expands AI Measurement With ChatGPT Ads Attribution Across App, Web and Desktop

New support helps advertisers connect paid ChatGPT Ads campaigns with organic AI traffic and every other customer acquisition channel MOUNTAIN VIEW, Calif., Sept. 24, 2026 /PRNewswire/ -- Branch, the linking and measurement partner for growth-focused brands, today announced support for...
Read more »

PR Public relations news



Historic Announcement: CenterPoint Energy Selected to Receive $50 Million U.S. Department of Energy Grant to Strengthen & Modernize Greater Houston's Electric Grid
Historic Announcement: CenterPoint Energy Selected to Receive $50 Million U.S. Department of Energy Grant to Strengthen & Modernize Greater Houston's Electric Grid
Global Bioinformatics Market to Reach USD 64.60 Billion by 2034, Driven by AI, Genomics, Next-Generation Sequencing, and Precision Medicine Report Maximize Market Research
Global Bioinformatics Market to Reach USD 64.60 Billion by 2034, Driven by AI, Genomics, Next-Generation Sequencing, and Precision Medicine Report Maximize Market Research
Pomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers - GUTS
Pomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers - GUTS
Pomerantz Law Firm Announces the Filing of a Class Action Against AST SpaceMobile, Inc. and Certain Officers - ASTS
Pomerantz Law Firm Announces the Filing of a Class Action Against AST SpaceMobile, Inc. and Certain Officers - ASTS
Pomerantz Law Firm Announces the Filing of a Class Action Against AppLovin Corporation and Certain Officers - APP
Pomerantz Law Firm Announces the Filing of a Class Action Against AppLovin Corporation and Certain Officers - APP
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lincoln Educational Services Corp. of Class Action Lawsuit and Upcoming Deadlines - LINC
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lincoln Educational Services Corp. of Class Action Lawsuit and Upcoming Deadlines - LINC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ServiceTitan, Inc. - TTAN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ServiceTitan, Inc. - TTAN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - OSIS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - OSIS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of lululemon athletica inc. - LULU
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of lululemon athletica inc. - LULU
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
McCormick Declares $0.48 Quarterly Dividend
Desktop versie